COVID-19 Vaccines - Malawi

  • Malawi
  • The COVID-19 Vaccines market in Malawi is forecasted to achieve a revenue of US$34.12m by the year 2024.
  • Over the period of 2024 to 2029, the market is anticipated to exhibit an annual growth rate (CAGR 2024-2029) of -18.47%, leading to a market volume of US$12.29m by 2029.
  • When compared globally, United States is expected to generate the highest revenue, amounting to US$4,389,000.00k in 2024.
  • Malawi is experiencing a surge in demand for COVID-19 vaccines due to increasing public awareness and government initiatives.

Key regions: United Kingdom, Germany, France, South Korea, Italy

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

Malawi, a landlocked country in southeastern Africa, has been making strides in the fight against COVID-19. As the world continues to grapple with the pandemic, Malawi has been able to secure a steady supply of COVID-19 vaccines, which has been crucial in curbing the spread of the virus.

Customer preferences:
The people of Malawi have shown a willingness to get vaccinated against COVID-19, which has been a positive development for the country's vaccination campaign. The government has been working hard to educate the public on the importance of getting vaccinated, and this has helped to increase vaccine uptake.

Trends in the market:
The COVID-19 vaccines market in Malawi has been growing steadily, with more and more people getting vaccinated every day. The government has been working closely with international organizations to secure a steady supply of vaccines, and this has helped to ensure that there are enough vaccines for everyone who needs them.

Local special circumstances:
Malawi is one of the poorest countries in the world, and this has presented unique challenges in the fight against COVID-19. However, the government has been able to leverage international support to secure vaccines and other resources needed to fight the pandemic. Additionally, the country has a strong healthcare system that has been able to effectively distribute vaccines to the population.

Underlying macroeconomic factors:
The COVID-19 pandemic has had a significant impact on the global economy, and Malawi has not been immune to this. However, the country has been able to secure international support to help mitigate the economic impact of the pandemic. Additionally, the government has been working to diversify the economy and reduce reliance on traditional exports such as tobacco.In conclusion, the COVID-19 vaccines market in Malawi has been growing steadily, thanks to the government's efforts to secure a steady supply of vaccines and educate the public on the importance of getting vaccinated. Despite being one of the poorest countries in the world, Malawi has been able to effectively distribute vaccines to the population, thanks to a strong healthcare system and international support. While the pandemic has had a significant impact on the global economy, Malawi has been working to mitigate the economic impact and diversify its economy for long-term sustainability.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)